… Unresectable lung cancer is typically represented by stage III and IV disease. Stage III lung
cancer is … As a type of surgical intervention for unresectable stage III lung cancer, we describe …

… normal tissues, including the heart, lung, and esophagus. After the introduction … stage IV
lung cancer, efforts to evaluate its benefit among patients with unresectable stage III lung cancer …

Stage III nonsmall cell lung cancer (NSCLC) encompasses a heterogeneous group of …
Recommended therapy for patients with unresectable stage III disease is concurrent treatment …

… patients with non-smaLLceLL Lung cancer (NSCLC) wiLL present with stage III disease [1]. …
[ities are reasonably we[[ established for stages I, II, and IV, the treatment of stage III disease …

… and squamous tumor histologic types as well as in patients with stages IIIA and … -cell
lung cancer, in which the correlation between the PD-L1 biomarker and benefit in advanced-stage …

… Approximately 30 to 40% of all patients with non-small-cell lung cancer have locally
unresectable disease at the time of initial assessment. Although which patients with stage IIIA …

… In this review, we present the results of clinical trials investigating immune therapy in
unresectable stage III NSCLC and discuss in-depth their biological rationale, their pitfalls and …

… III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation
docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier …

… in inoperable stage iii non-smallcell lung cancer: swog S0023. J Clin Oncol 2008;26:2450–6.
19. … for stage iii nonsmall-cell lung cancer (start): a randomised, double-blind, phase 3 trial. …

… The American Society of Clinical Oncology (ASCO) previously published evidencebased
guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC) [1]. ASCO …